Johnson & Johnson's experimental prostate cancer drug, JNJ-6143, has shown significant tumor shrinkage and reduced PSA levels ...
Zymeworks has entered a global licensing agreement with Roche to develop and commercialize its experimental lung cancer drug ...
A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...
Biocon has secured a license to introduce its Stelara biosimilar in nine additional countries, expanding treatment access for ...
AstraZeneca's late-stage trial data reveals significant improvements in overall survival for advanced stomach cancer patients using the drug sone-ve, outperforming chemotherapy and raising potential ...
Roche's investigational cancer drug divarasib significantly lowers the risk of death for patients with KRAS G12C-mutated ...
Takeda Pharmaceutical aims for regulatory approval in Japan for its promising gastric cancer drug, TAK-921, following ...
The inclusion of Dr. Naresh Trehan in a pharmaceutical marketing review panel faces backlash from patient groups over ...
Bristol Myers Squibb reveals a patient death during an early-stage trial of its experimental CAR-T cell therapy for multiple ...
Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...
J.P. Morgan projects that the GLP-1 drug market in China, India, and Brazil could reach $22 billion by 2035, driven by ...
AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results